• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » uBiome launches Clinical Lab

uBiome launches Clinical Lab

April 29, 2015
CenterWatch Staff

San Francisco-based uBiome has launched a CLIA-regulated clinical laboratory to provide clinical tests based on its unique microbial assays.

Founded in 2012, the biotech startup engaged the public to provide easily accessible information about their own bodies using high-throughput DNA sequencing technology for the microbiome. uBiome has gathered millions of data points in collaboration with its citizen scientist participants and built unique bioinformatic and lab automation tools. These data have helped develop new clinical assays that will allow doctors and patients to obtain clinically relevant results. uBiome's CLIA laboratory was licensed in December 2014.

Clinical tests will be ordered by patients in collaboration with doctors. Research participants still will be able to participate in studies of the microbiome (including the gut microbiome, skin microbiome, nasal microbiome, genital microbiome, oral microbiome, interdental microbiome and others). Clinical tests will be differentiated clearly from research study results. Interested parties can sign up at www.ubiome.com/clinical.

“uBiome’s mission is to transform research into useful products based on the microbiome. Through our research partnerships with thousands of citizen scientists and dozens of universities, including Harvard, Stanford and UCSF, we have gathered millions of data points and built a set of tools that have enabled us to create clinical tests for doctors and patients,” said Jessica Richman, co-founder and CEO of uBiome.

uBiome will provide a fund for those who cannot afford to purchase clinical tests. Donations will be accepted from both research participants and patients who want to help those in need, and a portion of the proceeds from tests also will go to fund those who cannot afford them. All current and ongoing study participants will receive early access to these tests and other benefits.

The human microbiome has been called the greatest medical discovery of our age. These microbial symbionts are essential collaborators in our health. The correct balance of microbes serves to keep potential pathogens in check and regulate the immune system. Microbes also perform essential functions such as digesting food and synthesizing vitamins. Pathogenic and commensal bacteria play a role in health conditions ranging from autism to yellow fever.

Citizen science, the collaboration between professional scientists and members of the public, allows rapid collaboration on large-scale research questions and translation of the results to practice.

uBiome provides current research participants with a catalog of their own microbes, detailing the microbial composition of each sample, what is known about each type of microbe and the latest scientific research on the role of the microbiome in health, diet and lifestyle. uBiome has received $6.5 million in funding.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing